Advanced search
Publication Cover
HIV Clinical Trials Volume 12, 2011 - Issue 2
Submit an article Journal homepage
111
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study

Justyna D. KowalskaCopenhagen HIV Programme University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
,
Amanda MocroftUniversity College London Medical School Royal Free Campus, London, United Kingdom
,
Bruno LedergerberDivision of Infectious Diseases and Hospital Epidemiology University Hospital, University of Zurich, Zürich, Switzerland
,
Eric FlorenceInstitute of Tropical Medicine Medical Service, Antwerp, Belgium
,
Matti RistolaHelsinki University Central Hospital, Helsinki, Finland
,
Josip BegovacUniversity Hospital of Infectious Diseases Zagreb, Croatia
,
Helen SambatakouIppokration General Hospital University of Athens, Athens, Greece
,
Court PedersenOdense Universitetshospital Odense, Denmark
,
Jens D. LundgrenCopenhagen HIV Programme University of Copenhagen, Copenhagen, Denmark;Department of Infectious DiseasesRigshospitalet, Copenhagen, Denmark
,
Ole KirkCopenhagen HIV Programme University of Copenhagen, Copenhagen, Denmark;Department of Infectious DiseasesRigshospitalet, Copenhagen, Denmark
& EuroSIDA Study Group show all
Pages 109-117 | Published online: 06 Jan 2015

REFERENCES

  • Krantz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6(2):99–106.
  • Mortality of HIV-infected patients starting potent antiret-roviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol. 2009;38(6)1 624–1633.
  • Lohse N, Hansen AB, Pedersen G, et al. Survival of per-sons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007;146(2):87–95.
  • Jaggy C, von OJ, Ledergerber B, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet. 2003;362(9387):877–878.
  • Martinez E, Milinkovic A, Buira E, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med. 2007;8(4):251–258.
  • The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretro-viral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50(10):1387–1396.
  • Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590–598.
  • Rosenthal E, Salmon-Ceron D, Lewden C, et al. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19). HIV Med. 2009;10(5):282–289.
  • Monforte A, Abrams D, Pradier C, et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS. 2008;22(16):2143–2153.
  • Mann B, Thiebaut R, Bucher HC, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23(13)1 743–1753.
  • Zwahlen M, Lundgren JD. Commentary: death in the era of potent antiretroviral therapy: shifting causes, new chal-lenges. Int J Epidemiol. 2005;34(1):130–131.
  • Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: com-parison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. 1999;13(15):2075–2082.
  • Coding Causes of Death in HIV protocol version 1.0. CoDe Web site. February 2005. http://www.cphiv.dk/Portals/_default/pdf_folder/code_protocol_ver_1.0.pdf. Accessed February 2005.
  • Kowalska JD, Früs-Moller N, Kirk O, et al. The Coding Causes of Death in HIV (CoDe) Project - initial results and evaluation of methodology. The CoDe Working Group and the D:A:D Study Group. Epidemiology. In press.
  • The HIV-TB Project. The HIV-TB Project Web site. 2009. http://www.cphiv.dk/HIVTB/tabid/284/Default.aspx. Accessed February 2009.
  • Podlekareva D, Bannister W, Mocroft A, et al. The Euro-SIDA study: regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results. Cent Eur J Public Health. 2008;16(3):99–105.
  • Grabar S, Lanoy E, Allavena C, et al. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med. 2008;9(4):246–256.
  • Mocroft AJ, Lundgren JD, d'Armino MA, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol. 1997;26(2):400–407.
  • Mocroft A, Youle M, Morcinek J, et al. Survival after diag-nosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. BMJ. 1997;314(7078):409–413.
  • Landis JR, Koch GG. The measurement of observer agree-ment for categorical data. Biometrics. 1977;33(1)159–174.
  • Aung E, Rao C, Walker S. Teaching cause-of-death certi-fication: lessons from international experience. Postgrad Med J. 2010;86(1013)1 43–152.
  • Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009;361(16):1548–1559.
  • Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in prevent-ing AIDS and death: a prospective cohort study. Lancet. 2005;366(9483):378–384.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.